Filing Flows › LifeStance Health Group (LFST) › Q2 2026
LifeStance Health Group (LFST) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
LifeStance Health Group (LFST) reported revenue of $435M for the second quarter 2026 (Q2 2026), +26% from a year earlier and +8% from the quarter before. Operating margin was 7.0%, net earnings $23.6M (5.4% of revenue).
LifeStance Health Group, Q2 2026: revenue $435M (+26% year over year), operating margin 7.0%, net earnings $23.6M, operating cash flow $99.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $435M | +8% | +26% |
| Operating profit | $30.7M | +38% | — |
| Net earnings | $23.6M | +66% | — |
| Operating cash flow | $99.9M | +202% | +55% |
| Free cash flow | $87.9M | +294% | +55% |
What changed
Revenue was $435.4M in Q2 2026, up 26% year over year and up 8% from the previous quarter.
Operating profit was $30.7M, a 7.0% margin (up 7.9 points year over year). Total costs grew 16% against revenue growth of 26%. The fastest-growing cost line was Other operating costs (+18%). Net earnings were $23.6M. The effective tax rate was 14.0%.
Operating cash flow was $99.9M (up 55% year over year), 423% of net earnings. Non-cash charges added back $11.3M of depreciation and amortization and $19.7M of share-based compensation. Working capital and other items added $45.2M. Capital expenditures of $12.0M left free cash flow of $87.9M.
Questions
What was LifeStance Health Group's revenue in the second quarter 2026?
LifeStance Health Group (LFST) reported revenue of $435M for the second quarter 2026 (Q2 2026), +26% from a year earlier and +8% from the quarter before.
Was LifeStance Health Group profitable in the second quarter 2026?
Operating profit was $30.7M (7.0% of revenue) and net earnings $23.6M.